Micheline Gravelle is a partner with Bereskin & Parr LLP. She is also the leader of the Life Sciences and Cannabis practice groups.
Micheline’s practice focuses on assessing new technologies, preparing and prosecuting patent applications worldwide, and conducting due diligence analysis on patent portfolios.
She has work experience in the chemistry, microbiology, immunology and molecular biology fields, and has worked in the industry for multi-national companies, government agencies and in a hospital laboratory.
Micheline stays at the forefront of the life sciences industry, and regularly contributes to various publications, and is a speaker on the issues that affect IP in the industry.
Micheline is recognized as a top-tier professional in both national and international publications, including The Canadian Legal Lexpert Directory in the area of Biotechnology and Intellectual Property, Who’s Who Legal – Patents, IAM Patent 1000 – The World’s Leading Patent Practitioners, Lexpert/American Lawyer Guide to the Leading 500 Lawyers in Canada, and PLC Cross-border Life Sciences Handbook. More recently, Micheline was named a Preeminent Life Sciences Expert by LMG Life Sciences, an “IP Star” in Managing Intellectual Property’s IP Stars Handbook: Patent, and top patent practitioner in Expert Guides: Guide to the World’s Leading Women in Business Law and Expert Guides: Guide to the World's Leading Patent Law. In 2017, Micheline was recognized as the Canadian Patent Non-Contentious Attorney of the Year by LMG Life Sciences. Micheline was recognized among MIP's Top 250 Women in IP 2019.
